journal article·2019-12-04Open access

Chitosan nanoparticles induced the antitumor effect in hepatocellular carcinoma cells by regulating ROS-mediated mitochondrial damage and endoplasmic reticulum stress

Yibing Jiang, Xiwei Yu, Chang Su, Liang Zhao, Yijie Shi

Abstract

In recent years, numerous studies have confirmed the role of chitosan nanoparticles (CS NPs) as a promising drug delivery carrier for improving the efficiency of anticancer drug in the treatment of cancer. However, the possible biological effects of CS NPs on tumour cells and underlying mechanisms are still unclear. Recently, reactive oxygen species (ROS)-mediated cell apoptosis has been implicated in the regulation of cell death. In this study, we found that CS NPs induced the massive generation of ROS and resulted in apoptosis of hepatocellular carcinoma cells (SMMC-7721) through activating the mitochondrial pathway and endoplasmic reticulum stress. These results suggest an important role of ROS in CS NPs-induced cancer cell death.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced Nanomaterials in Catalysis · Advanced biosensing and bioanalysis techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Pharmacy, Jinzhou Medical University

School of Veterinary Medicine, Jinzhou Medical University

Funding

National Natural Science Foundation of China · Natural Science Foundation of Liaoning Province · Scientific Research Project of Liaoning Provincial Department of Education

References (26)

Show source-provided references
1. Jiang S, Franco YL, Zhou Y, et al. Nanotechnology in retinal drug delivery. Int J Ophthalmol. 2018;11:1038–1044.
2. 10.1021/acsnano.7b0510810.1021/acsnano.7b05108 ↗
3. 10.1002/anie.20140303610.1002/anie.201403036 ↗
4. 10.1038/nrc156610.1038/nrc1566 ↗
5. 10.1016/j.addr.2006.09.01110.1016/j.addr.2006.09.011 ↗
6. 10.1126/science.109583310.1126/science.1095833 ↗
7. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
8. 10.1088/0957-4484/18/38/38510210.1088/0957-4484/18/38/385102 ↗
9. 10.1126/science.300.5617.243a10.1126/science.300.5617.243a ↗
10. 10.1006/rtph.1995.101710.1006/rtph.1995.1017 ↗
11. 10.1093/toxsci/kfj02710.1093/toxsci/kfj027 ↗
12. 10.1289/ehp.600010.1289/ehp.6000 ↗
13. 10.1155/2013/31607510.1155/2013/316075 ↗
14. 10.1016/j.envres.2003.07.01110.1016/j.envres.2003.07.011 ↗
15. 10.1126/science.111439710.1126/science.1114397 ↗
16. 10.1166/jnn.2006.19410.1166/jnn.2006.194 ↗
17. 10.1016/j.freeradbiomed.2014.04.02610.1016/j.freeradbiomed.2014.04.026 ↗
18. 10.1016/j.tiv.2014.07.01010.1016/j.tiv.2014.07.010 ↗
19. 10.1016/j.carbpol.2017.04.09710.1016/j.carbpol.2017.04.097 ↗
20. 10.1016/j.ijbiomac.2016.12.09010.1016/j.ijbiomac.2016.12.090 ↗
21. 10.3762/bjnano.7.17810.3762/bjnano.7.178 ↗
22. 10.1016/j.carbpol.2016.12.00910.1016/j.carbpol.2016.12.009 ↗
23. 10.1016/j.ijpharm.2014.08.02610.1016/j.ijpharm.2014.08.026 ↗
24. 10.1186/s12951-014-0043-710.1186/s12951-014-0043-7 ↗
25. 10.1016/S0168-3659(01)00294-210.1016/S0168-3659(01)00294-2 ↗
26. 10.1016/S0378-5173(01)00760-810.1016/S0378-5173(01)00760-8 ↗